Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Clinical trial NCT05119296 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05119296
- Sponsor
- Stanford University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2025-05-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.